Curcumin inhibits phorbol myristate acetate (PMA)-induced MCP-1 expression by inhibiting ERK and NF-κB transcriptional activity

Food and Chemical Toxicology

Volumn 48, Issue 1, 2010, Pages 47-52

  Lim, Jun Hee ^a   Kwon, Taeg Kyu ^a  

^a Keimyung University   (South Korea)

Author keywords

Ap1; Curcumin; MCP 1; NF B; PMA; U937 cells

Indexed keywords

BAICALEIN; BAICALIN; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHORBOL 13 ACETATE 12 MYRISTATE; QUERCETIN; RESVERATROL; TRANSCRIPTION FACTOR AP 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN U937; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; TRANSACTIVATION; TRANSCRIPTION INITIATION; UPREGULATION;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL NUCLEUS; CHEMOKINE CCL2; COLORING AGENTS; CURCUMIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; LUCIFERASES; NF-KAPPA B; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TETRADECANOYLPHORBOL ACETATE; TETRAZOLIUM SALTS; THIAZOLES; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFECTION; U937 CELLS;

CURCUMA;

EID: 72149127647     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.09.013     Document Type: Article

References (28)

1. Aggarwal B.B., and Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trend Pharmacol. Sci. 30 (2009) 85-94
2. Baek W.K., Park J.W., Lim J.H., Suh S.I., Suh M.H., Gabrielson E., and Kwon T.K. Molecular cloning and characterization of the human budding uninhibited by benomyl (BUB3) promoter. Gene 295 (2002) 117-123
3. Baggiolini M., Dewald B., and Moser B. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55 (1994) 97-179
4. Boring L., Gosling J., Cleary M., and Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394 (1998) 894-897
5. Chen Y.M., Chiang W.C., Lin S.L., Wu K.D., Tsai T.J., and Hsieh B.S. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition. J. Pharmacol. Exp. Ther. 309 (2004) 978-986
6. Gescher A. Polyphenolic phytochemicals versus non-steroidal anti-inflammatory drugs: which are better cancer chemopreventive agents?. J. Chemother. 16 (2004) 3-6
7. Habtemariam S. Antiinflammatory activity of the antirheumatic herbal drug, gravel root (Eupatorium purpureum): further biological activities and constituents. Phytother. Res. 15 (2001) 687-690
8. Harvey E.J., Li N., and Ramji D.P. Critical role for casein kinase 2 and phosphoinositide-3-kinase in the interferon-gamma-induced expression of monocyte chemoattractant protein-1 and other key genes implicated in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 806-812
9. Hong K.H., Ryu J., and Han K.H. Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A. Blood 105 (2005) 1405-1407
10. Hong M.H., Kim M.H., Chang H.J., Kim N.H., Shin B.A., Ahn B.W., and Jung Y.D. (-)-Epigallocatechin-3-gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-kappaB signaling. Life Sci. 80 (2007) 1957-1965
11. Ip W.K., Wong C.K., and Lam C.W. Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways. Clin. Exp. Immunol. 145 (2006) 162-172
12. Kim Y.S., Ahn Y., Hong M.H., Joo S.Y., Kim K.H., Sohn I.S., Park H.W., Hong Y., Kim J.H., Kim W., Jeong M.H., Cho J.G., Park J.C., and Kang J.C. Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells. J. Cardiovasc. Pharmacol. 50 (2007) 41-49
13. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
14. Menon V.P., and Sudheer A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 595 (2007) 105-125
15. Nakayama K., Furusu A., Xu Q., Konta T., and Kitamura M. Unexpected transcriptional induction of monocyte chemoattractant protein 1 by proteasome inhibition: involvement of the c-Jun N-terminal kinase-activator protein 1 pathway. J. Immunol. 167 (2001) 1145-1150
16. Rahman I., Biswas S.K., and Kirkham P.A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 72 (2006) 1439-1452
17. Reyes-Gordillo K., Segovia J., Shibayama M., Vergara P., Moreno M.G., and Muriel P. Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. Biochim. Biophys. Acta 1770 (2007) 989-996
18. Schmitz M.L., and Baeuerle P.A. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J. 10 (1991) 3805-3817
19. Seino Y., Ikeda U., Takahashi M., Hojo Y., Irokawa M., Kasahara T., and Shimada K. Expression of monocyte chemoattractant protein-1 in vascular tissue. Cytokine 7 (1995) 575-579
20. Shoelson S.E., Lee J., and Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest. 116 (2006) 1793-1801
21. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3 (2003) 768-780
22. Takaya K., Koya D., Isono M., Sugimoto T., Sugaya T., Kashiwagi A., and Haneda M. Involvement of ERK pathway in albumin-induced MCP-1 expression in mouse proximal tubular cells. Am. J. Physiol. Renal Physiol. 284 (2003) 1037-1045
23. Teferedegne B., Green M.R., Guo Z., and Boss J.M. Mechanism of action of a distal NF-kappaB-dependent enhancer. Mol. Cell. Biol. 26 (2006) 5759-5770
24. Terkeltaub R., Boisvert W.A., and Curtiss L.K. Chemokines and atherosclerosis. Curr. Opin. Lipidol. 9 (1998) 397-405
25. Treves R., Maheu E., and Dreiser R.L. Therapeutic trials in digital osteoarthritis. A critical review. Rev. Rhum. Engl. Ed. 62 (1995) 33S-41S
26. Woo H.M., Kang J.H., Kawada T., Yoo H., Sung M.K., and Yu R. Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sci. 80 (2007) 926-931
27. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., Sarkioja T., Yoshimura T., Leonard E.J., Witztum J.L., and Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. 88 (1991) 5252-5256
28. Yoshimura H., Nakahama K., Safronova O., Tanaka N., Muneta T., and Morita I. Transforming growth factor-beta stimulates IL-1beta-induced monocyte chemoattractant protein-1 expression in human synovial cells via the ERK/AP-1 pathway. Inflamm. Res. 55 (2006) 543-549